NRIX
NASDAQ · Biotechnology
Nurix Therapeutics Inc
$15.15
+0.31 (+2.09%)
Open$15.00
Previous Close$14.84
Day High$15.53
Day Low$14.79
52W High$28.23
52W Low$11.67
Volume—
Avg Volume4.68M
Market Cap1.66B
P/E Ratio5.64
EPS$2.31
SectorBiotechnology
Analyst Ratings
Strong Buy
20 analysts
Price Target
+377.2% upside
Current
$15.15
$15.15
Target
$72.29
$72.29
$45.76
$72.29 avg
$82.91
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 106.32M | 82.07M | 234.23M |
| Net Income | -334,795,136 | -232,604,309 | -24,379,697 |
| Profit Margin | -314.9% | -299.2% | -10.4% |
| EBITDA | -350,583,633 | -257,105,489 | -31,389,191 |
| Free Cash Flow | — | — | -25,443,977 |
| Rev Growth | +29.5% | +29.5% | +16.3% |
| Debt/Equity | — | — | 0.64 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |